Clinical Trial Detail

NCT ID NCT02234115
Title Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma
Recruitment Completed
Gender male
Phase Phase III
Variant Requirements No
Sponsors Foreseeacer Pharmaceuticals, Inc.
Indications

prostate carcinoma

Therapies

Leuprolide

Age Groups: adult

No variant requirements are available.